Cargando…

Gene therapy targeting the blood–brain barrier improves neurological symptoms in a model of genetic MCT8 deficiency

A genetic deficiency of the solute carrier monocarboxylate transporter 8 (MCT8), termed Allan–Herndon–Dudley syndrome, is an important cause of X-linked intellectual and motor disability. MCT8 transports thyroid hormones across cell membranes. While thyroid hormone analogues improve peripheral chang...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sundaram, Sivaraj M, Arrulo Pereira, Adriana, Müller-Fielitz, Helge, Köpke, Hannes, De Angelis, Meri, Müller, Timo D, Heuer, Heike, Körbelin, Jakob, Krohn, Markus, Mittag, Jens, Nogueiras, Ruben, Prevot, Vincent, Schwaninger, Markus
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9762946/ https://www.ncbi.nlm.nih.gov/pubmed/35929549 http://dx.doi.org/10.1093/brain/awac243

Ejemplares similares

Is LRP2 Involved in Leptin Transport over the Blood-Brain Barrier and Development of Obesity?
por: Sandin, Elvira S., et al.
Publicado: (2021)

Distinct Actions of the Thyroid Hormone Transporters Mct8 and Oatp1c1 in Murine Adult Hippocampal Neurogenesis
por: Mayerl, Steffen, et al.
Publicado: (2022)

Tanycytes control the hormonal output of the hypothalamic-pituitary-thyroid axis
por: Müller-Fielitz, Helge, et al.
Publicado: (2017)

MCH Neurons Regulate Permeability of the Median Eminence Barrier
por: Jiang, Hong, et al.
Publicado: (2020)

NF-κB signaling in tanycytes mediates inflammation-induced anorexia
por: Böttcher, Mareike, et al.
Publicado: (2020)

Nesfatin-1 decreases the motivational and rewarding value of food
por: Dore, Riccardo, et al.
Publicado: (2020)

Absence of Both Thyroid Hormone Transporters MCT8 and OATP1C1 Impairs Neural Stem Cell Fate in the Adult Mouse Subventricular Zone
por: Luongo, Cristina, et al.
Publicado: (2021)

Triac Treatment Prevents Neurodevelopmental and Locomotor Impairments in Thyroid Hormone Transporter Mct8/Oatp1c1 Deficient Mice
por: Chen, Jiesi, et al.
Publicado: (2023)

Development and validation of an LC-MS/MS methodology for the quantification of thyroid hormones in dko MCT8/OATP1C1 mouse brain
por: De Angelis, Meri, et al.
Publicado: (2022)

A brain microvasculature endothelial cell‐specific viral vector with the potential to treat neurovascular and neurological diseases
por: Körbelin, Jakob, et al.
Publicado: (2016)

In atrial fibrillation epilepsy risk differs between oral anticoagulants: active comparator, nested case-control study
por: Platzbecker, Katharina, et al.
Publicado: (2023)

Deafness and loss of cochlear hair cells in the absence of thyroid hormone transporters Slc16a2 (Mct8) and Slc16a10 (Mct10)
por: Sharlin, David S., et al.
Publicado: (2018)

Genetic and Neurological Deficiencies in the Visual System of mct8 Mutant Zebrafish
por: Rozenblat, Rotem, et al.
Publicado: (2022)

The SARS-CoV-2 main protease M(pro) causes microvascular brain pathology by cleaving NEMO in brain endothelial cells
por: Wenzel, Jan, et al.
Publicado: (2021)

The LepR-mediated leptin transport across brain barriers controls food reward
por: Di Spiezio, Alessandro, et al.
Publicado: (2017)

A novel strategy for delivering Niemann‐Pick type C2 proteins across the blood–brain barrier using the brain endothelial‐specific AAV‐BR1 virus
por: Rasmussen, Charlotte Laurfelt Munch, et al.
Publicado: (2022)

Thyroid Hormone Transporters MCT8 and OATP1C1 Control Skeletal Muscle Regeneration
por: Mayerl, Steffen, et al.
Publicado: (2018)

Validation of Mct8/Oatp1c1 dKO mice as a model organism for the Allan-Herndon-Dudley Syndrome
por: Maity-Kumar, Gandhari, et al.
Publicado: (2022)

Natural Autoimmunity to the Thyroid Hormone Monocarboxylate Transporters MCT8 and MCT10
por: Porst, Theresa, et al.
Publicado: (2021)

Inhibition of Hypothalamic MCT4 and MCT1–MCT4 Expressions Affects Food Intake and Alters Orexigenic and Anorexigenic Neuropeptide Expressions
por: Elizondo-Vega, Roberto, et al.
Publicado: (2019)

SAT-562 Thyroid Hormone Transporter Mct8 is Specially Expressed in the Adrenal Gland Inner Cortex and Partially Mediates the Thyroid Hormone Action in the Adrenal Cortex.
por: Cleary, Courtney, et al.
Publicado: (2019)

Optimisation of immunofluorescence methods to determine MCT1 and MCT4 expression in circulating tumour cells
por: Kershaw, Stephen, et al.
Publicado: (2015)

Functional heterogeneity of MCT1 and MCT4 in metabolic reprogramming affects osteosarcoma growth and metastasis
por: Sheng, Gaohong, et al.
Publicado: (2023)

TRIAC Treatment Improves Impaired Brain Network Function and White Matter Loss in Thyroid Hormone Transporter Mct8/Oatp1c1 Deficient Mice
por: Reinwald, Jonathan Rochus, et al.
Publicado: (2022)

Insights Into the Mechanism of MCT8 Oligomerization
por: Groeneweg, Stefan, et al.
Publicado: (2020)

Tissue expression of lactate transporters (MCT1 and MCT4) and prognosis of malignant pleural mesothelioma (brief report)
por: Dell’Anno, Irene, et al.
Publicado: (2020)

Proteome Analysis of Thyroid Hormone Transporter Mct8/Oatp1c1-Deficient Mice Reveals Novel Dysregulated Target Molecules Involved in Locomotor Function
por: Siemes, Devon, et al.
Publicado: (2023)

Establishing Patient-Centered Outcomes for MCT8 Deficiency: Stakeholder Engagement and Systematic Literature Review
por: Wilpert, Nina-Maria, et al.
Publicado: (2023)

Critical Velocity, Maximal Lactate Steady State, and Muscle MCT1 and MCT4 after Exhaustive Running in Mice
por: Orsi, Juan B., et al.
Publicado: (2023)

Expression Pattern of Thyroid Hormone Transporters in the Postnatal Mouse Brain
por: Müller, Julia, et al.
Publicado: (2014)

MCT4 blockade increases the efficacy of immune checkpoint blockade
por: Babl, Nathalie, et al.
Publicado: (2023)

MCT1 is a predictive marker for lenalidomide maintenance therapy in multiple myeloma
por: Stroh, Jacob, et al.
Publicado: (2022)

Marked Seizure Reduction after MCT Supplementation
por: Azzam, Raed, et al.
Publicado: (2013)

Cancer metabolism, stemness and tumor recurrence: MCT1 and MCT4 are functional biomarkers of metabolic symbiosis in head and neck cancer
por: Curry, Joseph M., et al.
Publicado: (2013)

MCT1 and MCT4 Expression and Lactate Flux Activity Increase During White and Brown Adipogenesis and Impact Adipocyte Metabolism
por: Petersen, Charlotte, et al.
Publicado: (2017)

Dual Inhibition of the Lactate Transporters MCT1 and MCT4 Is Synthetic Lethal with Metformin due to NAD+ Depletion in Cancer Cells
por: Benjamin, Don, et al.
Publicado: (2018)

Role of Human Monocarboxylate Transporter 1 (hMCT1) and 4 (hMCT4) in Tumor Cells and the Tumor Microenvironment
por: Liu, Tian, et al.
Publicado: (2023)

Monocarboxylate Transporters 1–4 in NSCLC: MCT1 Is an Independent Prognostic Marker for Survival
por: Eilertsen, Marte, et al.
Publicado: (2014)

Obese patients with NASH have increased hepatic expression of SARS-CoV-2 critical entry points
por: Fondevila, Marcos F., et al.
Publicado: (2021)

The Amino Acid Transporter Mct10/Tat1 Is Important to Maintain the TSH Receptor at Its Canonical Basolateral Localization and Assures Regular Turnover of Thyroid Follicle Cells in Male Mice
por: Venugopalan, Vaishnavi, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_sne6hc8e1pnds8cv4n8laa7uv9